DHG Pharmaceutical JSC 2020 SR
The report highlights DHG Pharma's resilience and commitment to sustainable development during the 2020 COVID-19 pandemic. Key achievements include maintaining its leading position in Vietnam's pharmaceutical industry with record profit after tax of VND 739 billion and obtaining Japan-GMP certification for production lines. DHG Pharma contributed nearly VND 12 billion to COVID-19 prevention and flood relief efforts. Environmental initiatives resulted in a 6.3% wastewater recycle rate and zero environmental violations. The company also ensured stable employment and welfare for over 2,700 employees nationwide.
Company: DHG Pharmaceutical JSC
Sector: Manufacturing
Country: Vietnam
Year: 2020
Type: SR
Pages: 75
DHG Pharmaceutical JSC
The report highlights DHG Pharma's resilience and commitment to sustainable development during the 2020 COVID-19 pandemic. Key achievements include maintaining its leading position in Vietnam's pharmaceutical industry with record profit after tax of VND 739 billion and obtaining Japan-GMP certification for production lines. DHG Pharma contributed nearly VND 12 billion to COVID-19 prevention and flood relief efforts. Environmental initiatives resulted in a 6.3% wastewater recycle rate and zero environmental violations. The company also ensured stable employment and welfare for over 2,700 employees nationwide.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Published
Apr 19, 2021
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Energy Consumption
Water Consumption
Total Waste
Women in Management
Workplace Fatalities
Employees